Skip to content
Screener

PACS Group PACS Reportable Segment — Income (Loss) from Equity Method Investments

Similar metrics at other companies

BridgeBio Pharma logo
BBIOReportable Segment — Income (Loss) from Equity Method Investments
-$18.28M-17.5%
Accel Entertainment logo
ACELReportable Segment — Income (Loss) from Equity Method Investments
-$16K0.0%
Freshpet logo
FRPTReportable Segment — Income (Loss) from Equity Method Investments
$0
Ryan Specialty Holdings logo
RYANReporting Segment — Income (Loss) from Equity Method Investments
$5.53M+12.0%
Beyond Meat logo
BYNDReporting Segment — Income (Loss) from Equity Method Investments
-$16K+72.9%
Nextra Energy logo
NEENEER Segment — Income (Loss) from Equity Method Investments
$333M+88.1%

Other financials

Income statement

See full
Revenue$1.4B+11.2%
Gross profit$346.0M+36.5%
Operating income$120.0M+149%
Net income$80.7M+183%
EPS (diluted)$0.50+194%

Balance sheet

See full
Cash & equivalents$273.7M-5.8%
Total debt$3.5B-3.2%
Total equity$1.0B+38.2%
Total assets$5.7B+3.1%

Cash flow

See full
Operating cash flow$236.3M+57.3%
CapEx$21.8M+23.2%
Free cash flow$214.5M+61.9%

Valuation

See full
Market cap$7.39B+331%
Enterprise value$10.58B+112%
P/E30.3×+17.3×
P/S1.4×+1.0×

Profitability

See full
Gross margin23%+3.7pp
Operating margin7%+4.6pp
Net margin4.5%+3.4pp
FCF margin7.7%

Returns & leverage

See full
Return on equity27.3%+15.8pp
Debt / equity3.3×-1.4×
Current ratio0.0×

Where this comes from

Reported directly by PACS Group in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The source filing: PACS Group’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:17 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0002001184-26-000023
Line itemThree months ended March 31, 2026Three months ended March 31, 2025
Less:
Labor expense(1)727,894677,020
Depreciation and amortization18,07712,705
Interest expense, net6,4246,904
Equity in the net (income) loss of investees accounted for under the equity method(455)298
Provision for income taxes33,06814,350
Other segment items(2)554,818537,493
Segment net income$80,668$28,380

Item 1. Financial Statements (unaudited)

FAQ

What is PACS Group's reportable segment — income (loss) from equity method investments?
PACS Group (PACS) reported reportable segment — income (loss) from equity method investments of $455K in Q1 2026.
How has PACS Group's reportable segment — income (loss) from equity method investments changed year-over-year?
PACS Group's reportable segment — income (loss) from equity method investments increased by 252.7% year-over-year, from -$298K to $455K.
What is the long-term trend for PACS Group's reportable segment — income (loss) from equity method investments?
Over 3 years (2022 to 2025), PACS Group's reportable segment — income (loss) from equity method investments has grown at a 32.2% compound annual growth rate (CAGR), from -$346K to -$800K.
What does reportable segment — income (loss) from equity method investments mean?
This represents the segment's proportional share of the net earnings or losses from entities where the company exercises significant influence but does not have full control. It highlights the performance of strategic partnerships and joint ventures within the healthcare ecosystem.

Ask your AI about PACS Group's reportable segment — income (loss) from equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude